Federal contract award
HHSO100201500009C
IGF::OT::IGF OBJECTIVE: MODIFY THE HIGHLY PROVEN ORAQUICK TEST PLATFORMTO ENABLE ANTIGEN DETECTION OF EBOLA ZAIRE FOR USE WITH AVARIETY OF SAMPLE TYPES: FINGERSTICK WHOLE BLOOD, PLASMA,AND ORAL FLUID.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 541711 |
| PSC | AN13 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $10.6M |
| Current contract value | $10.6M |
| Potential contract value / ceiling | $10.6M |
| Start date | Jun 2, 2015 |
| Current end date | Aug 31, 2022 |
| Potential end date | Aug 31, 2022 |
| Latest award activity | May 6, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 6, 2026 | P00016 | $-39.4K | THE PURPOSE OF THIS BILATERAL CONTRACT MODIFICATION IS TO DEOBLIGATE UNUSED FUNDS AND CLOSE OUT THE CONTRACT. |
| Sep 4, 2025 | P00015 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO TRANSFER ALL GOVERNMENT PROPERTY THAT RESIDES ON THIS CONTRACT TO CONTRACT 75A50122C00079. THE FULL INVENTORY LIST IS INCLUDED WITHIN THE CONTRACT MODIFICATION. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.